Accordingly, flow cytometry showed that NAFLD-HCC induced the recruitment of effector IL-10+ Tregs, thus attenuating the expansion of cytotoxic CD8+ T cells [28]. The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatotic liver disease.